Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.76
0.00 (0.00%)
At close: Jun 18, 2025, 4:00 PM
17.13
-0.63 (-3.55%)
Pre-market: Jun 20, 2025, 4:00 AM EDT
Apellis Pharmaceuticals Employees
As of December 31, 2024, Apellis Pharmaceuticals had 710 total employees, including 705 full-time and 5 part-time employees. The number of employees increased by 4 or 0.57% compared to the previous year.
Employees
710
Change (1Y)
4
Growth (1Y)
0.57%
Revenue / Employee
$1,092,731
Profits / Employee
-$315,042
Market Cap
2.23B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
APLS News
- 13 days ago - Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN - GlobeNewsWire
- 16 days ago - Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Apellis Pharmaceuticals: Have Some Patience - Seeking Alpha
- 6 weeks ago - Apellis Pharmaceuticals, Inc. (APLS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Apellis Announces Craig Wheeler to Join the Board of Directors - GlobeNewsWire